Prion protein: From physiology to cancer biology

Cancer Letters

Volumn 290, Issue 1, 2010, Pages 1-23

  Mehrpour, Maryam ^a   Codogno, Patrice ^a  

^a INSERM   (France)

Author keywords

Apoptosis; Breast; Drug resistance; Metastasis; Prostate and gastric cancer

Indexed keywords

ANTHRACYCLINE; ANTINEOPLASTIC ANTIMETABOLITE; COPPER; LIGAND; PACLITAXEL; PLATINUM COMPLEX; PRION PROTEIN; PROTEIN BAX; TAXANE DERIVATIVE; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; AUTOPHAGY; BREAST CANCER; CANCER CELL; CANCER CHEMOTHERAPY; CANCER GROWTH; CANCER SURGERY; CANCER SURVIVAL; CELL ADHESION; CELL CYCLE G1 PHASE; CELL CYCLE S PHASE; CELL MIGRATION; CELL PROLIFERATION; CELL PROTECTION; CELL TYPE; CELLULAR DISTRIBUTION; ENDOCYTOSIS; GASTROINTESTINAL TRACT; GLIOBLASTOMA; HEART; HUMAN; IMMUNE SYSTEM; IN VITRO STUDY; INTERNALIZATION; KIDNEY; LUNG; LYMPHOID CELL; MALIGNANT NEOPLASTIC DISEASE; MAMMARY GLAND; MUSCLE; NERVOUS SYSTEM; NEUROPROTECTION; NONHUMAN; OXIDATIVE STRESS; PHENOTYPE; PRION DISEASE; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN EXPRESSION; PROTEIN STRUCTURE; SHORT SURVEY; SIGNAL TRANSDUCTION; STOMACH CANCER;

EID: 77549087970     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canlet.2009.07.009     Document Type: Review

References (184)

1. Aguzzi A., and Polymenidou M. Mammalian prion biology: one century of evolving concepts. Cell 116 (2004) 313-327
2. Prusiner S.B. The prion diseases. Brain Pathol. 8 (1998) 499-513
3. Bueler H. Mice devoid of PrP are resistant to scrapie. Cell 73 (1993) 1339-1347
4. Aguzzi A., Baumann F., and Bremer J. The prion's elusive reason for being. Annu. Rev. Neurosci. 31 (2008) 439-477
5. Gousset K., and Zurzolo C. Tunnelling nanotubes: a highway for prion spreading?. Prion 3 (2009)
6. Heikenwalder M., Kurrer M.O., Margalith I., Kranich J., Zeller N., Haybaeck J., Polymenidou M., Matter M., Bremer J., Jackson W.S., Lindquist S., Sigurdson C.J., and Aguzzi A. Lymphotoxin-dependent prion replication in inflammatory stromal cells of granulomas. Immunity 29 (2008) 998-1008
7. Pauly P.C., and Harris D.A. Copper stimulates endocytosis of the prion protein. J. Biol. Chem. 273 (1998) 33107-33110
8. Mange A., Milhavet O., Umlauf D., Harris D., and Lehmann S. PrP-dependent cell adhesion in N2a neuroblastoma cells. FEBS Lett. 514 (2002) 159-162
9. Linden R., Martins V.R., Prado M.A., Cammarota M., Izquierdo I., and Brentani R.R. Physiology of the prion protein. Physiol. Rev. 88 (2008) 673-728
10. Caughey B., and Baron G.S. Prions and their partners in crime. Nature 443 (2006) 803-810
11. Westergard L., Christensen H.M., and Harris D.A. The cellular prion protein (PrP(C)): its physiological function and role in disease. Biochim. Biophys. Acta 1772 (2007) 629-644
12. Kovacs G.G., and Budka H. Prion diseases: from protein to cell pathology. Am. J. Pathol. 172 (2008) 555-565
13. Makrinou E., Collinge J., and Antoniou M. Genomic characterization of the human prion protein (PrP) gene locus. Mamm. Genome 13 (2002) 696-703
14. Medori R., Tritschler H.J., LeBlanc A., Villare F., Manetto V., Chen H.Y., Xue R., Leal S., Montagna P., Cortelli P., et al. Fatal familial insomnia, a prion disease with a mutation at codon 178 of the prion protein gene. N. Engl. J. Med. 326 (1992) 444-449
15. Gambetti P., Kong Q., Zou W., Parchi P., and Chen S.G. Sporadic and familial CJD: classification and characterisation. Br. Med. Bull. 66 (2003) 213-239
16. Meslin F., Conforti R., Mazouni C., Morel N., Tomasic G., Drusch F., Yacoub M., Sabourin J.C., Grassi J., Delaloge S., Mathieu M.C., Chouaib S., Andre F., and Mehrpour M. Efficacy of adjuvant chemotherapy according to prion protein expression in patients with estrogen receptor-negative breast cancer. Ann. Oncol. 18 (2007) 1793-1798
17. Didier A., Dietrich R., Steffl M., Gareis M., Groschup M.H., Muller-Hellwig S., Martlbauer E., and Amselgruber W.M. Cellular prion protein in the bovine mammary gland is selectively expressed in active lactocytes. J. Histochem. Cytochem. 54 (2006) 1255-1261
18. Sakaguchi S. Physiological functions of prion protein and its roles in the pathogenesis of prion diseases. Seikagaku 79 (2007) 843-852
19. Comincini S., Ferrara V., Arias A., Malovini A., Azzalin A., Ferretti L., Benericetti E., Cardarelli M., Gerosa M., Passarin M.G., Turazzi S., and Bellazzi R. Diagnostic value of PRND gene expression profiles in astrocytomas: relationship to tumor grades of malignancy. Oncol. Rep. 17 (2007) 989-996
20. Watts J.C., Drisaldi B., Ng V., Yang J., Strome B., Horne P., Sy M.S., Yoong L., Young R., Mastrangelo P., Bergeron C., Fraser P.E., Carlson G.A., Mount H.T., Schmitt-Ulms G., and Westaway D. The CNS glycoprotein Shadoo has PrP(C)-like protective properties and displays reduced levels in prion infections. EMBO J. 26 (2007) 4038-4050
21. Stahl N., and Prusiner S.B. Prions and prion proteins. FASEB J. 5 (1991) 2799-2807
22. Stewart R.S., and Harris D.A. Mutational analysis of topological determinants in prion protein (PrP) and measurement of transmembrane and cytosolic PrP during prion infection. J. Biol. Chem. 278 (2003) 45960-45968
23. Chakrabarti O., and Hegde R.S. Functional depletion of mahogunin by cytosolically exposed prion protein contributes to neurodegeneration. Cell 137 (2009) 1136-1147
24. Stewart R.S., and Harris D.A. A transmembrane form of the prion protein is localized in the Golgi apparatus of neurons. J. Biol. Chem. 280 (2005) 15855-15864
25. Meslin F., Hamai A., Gao P., Jalil A., Cahuzac N., Chouaib S., and Mehrpour M. Silencing of prion protein sensitizes breast adriamycin-resistant carcinoma cells to TRAIL-mediated cell death. Cancer Res. 67 (2007) 10910-10919
26. Hooper N.M. Roles of proteolysis and lipid rafts in the processing of the amyloid precursor protein and prion protein. Biochem. Soc. Trans. 33 (2005) 335-338
27. Pan K.M., Stahl N., and Prusiner S.B. Purification and properties of the cellular prion protein from Syrian hamster brain. Protein Sci. 1 (1992) 1343-1352
28. Jimenez-Huete A., Lievens P.M., Vidal R., Piccardo P., Ghetti B., Tagliavini F., Frangione B., and Prelli F. Endogenous proteolytic cleavage of normal and disease-associated isoforms of the human prion protein in neural and non-neural tissues. Am. J. Pathol. 153 (1998) 1561-1572
29. Shyng S.-L., Huber M.T., and Harris D.A. A prion protein cycles between the cell surface and an endocytic compartment in cultured neuroblastoma cells. J. Biol. Chem. 268 (1993) 15922-15928
30. Nieznanski K., Nieznanska H., Skowronek K.J., Osiecka K.M., and Stepkowski D. Direct interaction between prion protein and tubulin. Biochem. Biophys. Res. Commun. 334 (2005) 403-411
31. Mange A., Beranger F., Peoc'h K., Onodera T., Frobert Y., and Lehmann S. Alpha- and beta-cleavages of the amino-terminus of the cellular prion protein. Biol. Cell 96 (2004) 125-132
32. Vincent B., Paitel E., Frobert Y., Lehmann S., Grassi J., and Checler F. Phorbol ester-regulated cleavage of normal prion protein in HEK293 human cells and murine neurons. J. Biol. Chem. 275 (2000) 35612-35616
33. Vincent B., Paitel E., Saftig P., Frobert Y., Hartmann D., De Strooper B., Grassi J., Lopez-Perez E., and Checler F. The disintegrins ADAM10 and TACE contribute to the constitutive and phorbol ester-regulated normal cleavage of the cellular prion protein. J. Biol. Chem. 276 (2001) 37743-37746
34. Taraboulos A., Raeber A., Borchelt D.R., Serban D., and Prusiner S.B. Synthesis and trafficking of prion proteins in cultured cells. Mol. Biol. Cell 3 (1992) 851-863
35. Watt N.T., Taylor D.R., Gillott A., Thomas D.A., Perera W.S., and Hooper N.M. Reactive oxygen species-mediated beta-cleavage of the prion protein in the cellular response to oxidative stress. J. Biol. Chem. 280 (2005) 35914-35921
36. Hegde R.S., Mastrianni J.A., Scott M.R., DeFea K.A., Tremblay P., Torchia M., DeArmond S.J., Prusiner S.B., and Lingappa V.R. A transmembrane form of the prion protein in neurodegenerative disease. Science 279 (1998) 827-834
37. Stewart R.S., Piccardo P., Ghetti B., and Harris D.A. Neurodegenerative illness in transgenic mice expressing a transmembrane form of the prion protein. J. Neurosci. 25 (2005) 3469-3477
38. Juanes M.E., Elvira G., Garcia-Grande A., Calero M., and Gasset M. Biosynthesis of prion protein nucleocytoplasmic isoforms by alternative initiation of translation. J. Biol. Chem. 284 (2009) 2787-2794
39. Crozet C., Beranger F., and Lehmann S. Cellular pathogenesis in prion diseases. Vet. Res. 39 (2008) 44
40. Ma J., Wollmann R., and Lindquist S. Neurotoxicity and neurodegeneration when PrP accumulates in the cytosol. Science 298 (2002) 1781-1785
41. Mange A., Crozet C., Lehmann S., and Beranger F. Scrapie-like prion protein is translocated to the nuclei of infected cells independently of proteasome inhibition and interacts with chromatin. J. Cell Sci. 117 (2004) 2411-2416
42. Lorenz H., Windl O., and Kretzschmar H.A. Cellular phenotyping of secretory and nuclear prion proteins associated with inherited prion diseases. J. Biol. Chem. 277 (2002) 8508-8516
43. Sbalchiero E., Azzalin A., Palumbo S., Barbieri G., Arias A., Simonelli L., Ferretti L., and Comincini S. Altered cellular distribution and sub-cellular sorting of doppel (Dpl) protein in human astrocytoma cell lines. Cell Oncol. 30 (2008) 337-347
44. Prado M.A., Alves-Silva J., Magalhaes A.C., Prado V.F., Linden R., Martins V.R., and Brentani R.R. PrPc on the road: trafficking of the cellular prion protein. J. Neurochem. 88 (2004) 769-781
45. Hooper N.M., Taylor D.R., and Watt N.T. Mechanism of the metal-mediated endocytosis of the prion protein. Biochem. Soc. Trans. 36 (2008) 1272-1276
46. Harris D.A. Trafficking, turnover and membrane topology of PrP. Br. Med. Bull. 66 (2003) 71-85
47. Nunziante M., Gilch S., and Schatzl H.M. Essential role of the prion protein N terminus in subcellular trafficking and half-life of cellular prion protein. J. Biol. Chem. 278 (2003) 3726-3734
48. Perera W.S., and Hooper N.M. Ablation of the metal ion-induced endocytosis of the prion protein by disease-associated mutation of the octarepeat region. Curr. Biol. 11 (2001) 519-523
49. Sunyach C., Jen A., Deng J., Fitzgerald K.T., Frobert Y., Grassi J., McCaffrey M.W., and Morris R. The mechanism of internalization of glycosylphosphatidylinositol-anchored prion protein. EMBO J. 22 (2003) 3591-3601
50. Marella M., Lehmann S., Grassi J., and Chabry J. Filipin prevents pathological prion protein accumulation by reducing endocytosis and inducing cellular PrP release. J. Biol. Chem. 277 (2002) 25457-25464
51. Kaneko K., Vey M., Scott M., Pilkuhn S., Cohen F.E., and Prusiner S.B. COOH-terminal sequence of the cellular prion protein directs subcellular trafficking and controls conversion into the scrapie isoform. Proc. Natl. Acad. Sci. USA 94 (1997) 2333-2338
52. Sabharanjak S., Sharma P., Parton R.G., and Mayor S. GPI-anchored proteins are delivered to recycling endosomes via a distinct cdc42-regulated, clathrin-independent pinocytic pathway. Dev. Cell 2 (2002) 411-423
53. Johannes L., and Lamaze C. Clathrin-dependent or not: is it still the question?. Traffic 3 (2002) 443-451
54. Peters P.J., Mironov Jr. A., Peretz D., van Donselaar E., Leclerc E., Erpel S., DeArmond S.J., Burton D.R., Williamson R.A., Vey M., and Prusiner S.B. Trafficking of prion proteins through a caveolae-mediated endosomal pathway. J. Cell Biol. 162 (2003) 703-717
55. Sarnataro D., Caputo A., Casanova P., Puri C., Paladino S., Tivodar S.S., Campana V., Tacchetti C., and Zurzolo C. Lipid rafts and clathrin cooperate in the internalization of PrP in epithelial FRT cells. PloS one 4 (2009) e5829
56. Mouillet-Richard S., Ermonval M., Chebassier C., Laplanche J.L., Lehmann S., Launay J.M., and Kellermann O. Signal transduction through prion protein. Science 289 (2000) 1925-1928
57. Sunyach C., and Checler F. Combined pharmacological, mutational and cell biology approaches indicate that p53-dependent caspase 3 activation triggered by cellular prion is dependent on its endocytosis. J. Neurochem. 92 (2005) 1399-1407
58. Taylor D.R., Watt N.T., Perera W.S., and Hooper N.M. Assigning functions to distinct regions of the N-terminus of the prion protein that are involved in its copper-stimulated, clathrin-dependent endocytosis. J. Cell Sci. 118 (2005) 5141-5153
59. Gauczynski S., Peyrin J.M., Haik S., Leucht C., Hundt C., Rieger R., Krasemann S., Deslys J.P., Dormont D., Lasmezas C.I., and Weiss S. The 37-kDa/67-kDa laminin receptor acts as the cell-surface receptor for the cellular prion protein. EMBO J. 20 (2001) 5863-5875
60. Gauczynski S., Hundt C., Leucht C., and Weiss S. Interaction of prion proteins with cell surface receptors, molecular chaperones, and other molecules. Adv. Protein Chem. 57 (2001) 229-272
61. Taylor D.R., and Hooper N.M. The low-density lipoprotein receptor-related protein 1 (LRP1) mediates the endocytosis of the cellular prion protein. Biochem. J. 402 (2007) 17-23
62. Parkyn C.J., Vermeulen E.G., Mootoosamy R.C., Sunyach C., Jacobsen C., Oxvig C., Moestrup S., Liu Q., Bu G., Jen A., and Morris R.J. LRP1 controls biosynthetic and endocytic trafficking of neuronal prion protein. J. Cell Sci. 121 (2008) 773-783
63. Blasi F., and Carmeliet P. uPAR: a versatile signalling orchestrator. Nat. Rev. Mol. Cell Biol. 3 (2002) 932-943
64. Lee K.S., Linden R., Prado M.A., Brentani R.R., and Martins V.R. Towards cellular receptors for prions. Rev. Med. Virol. 13 (2003) 399-408
65. Hundt C., Peyrin J.M., Haik S., Gauczynski S., Leucht C., Rieger R., Riley M.L., Deslys J.P., Dormont D., Lasmezas C.I., and Weiss S. Identification of interaction domains of the prion protein with its 37-kDa/67-kDa laminin receptor. EMBO J. 20 (2001) 5876-5886
66. Zuber C., Knackmuss S., Zemora G., Reusch U., Vlasova E., Diehl D., Mick V., Hoffmann K., Nikles D., Frohlich T., Arnold G.J., Brenig B., Wolf E., Lahm H., Little M., and Weiss S. Invasion of tumorigenic HT1080 cells is impeded by blocking or downregulating the 37-kDa/67-kDa laminin receptor. J. Mol. Biol. 378 (2008) 530-539
67. Li A., Barmada S.J., Roth K.A., and Harris D.A. N-terminally deleted forms of the prion protein activate both Bax-dependent and Bax-independent neurotoxic pathways. J. Neurosci. 27 (2007) 852-859
68. Baumann F., Tolnay M., Brabeck C., Pahnke J., Kloz U., Niemann H.H., Heikenwalder M., Rulicke T., Burkle A., and Aguzzi A. Lethal recessive myelin toxicity of prion protein lacking its central domain. EMBO J. 26 (2007) 538-547
69. Shmerling D., Hegyi I., Fischer M., Blattler T., Brandner S., Gotz J., Rulicke T., Flechsig E., Cozzio A., von Mering C., Hangartner C., Aguzzi A., and Weissmann C. Expression of amino-terminally truncated PrP in the mouse leading to ataxia and specific cerebellar lesions. Cell 93 (1998) 203-214
70. Millhauser G.L. Copper and the prion protein: methods, structures, function, and disease. Ann. Rev. Phys. Chem. 58 (2007) 299-320
71. Viles J.H., Klewpatinond M., and Nadal R.C. Copper and the structural biology of the prion protein. Biochem. Soc. Trans. 36 (2008) 1288-1292
72. Gonzalez-Iglesias R., Pajares M.A., Ocal C., Espinosa J.C., Oesch B., and Gasset M. Prion protein interaction with glycosaminoglycan occurs with the formation of oligomeric complexes stabilized by Cu(II) bridges. J. Mol. Biol. 319 (2002) 527-540
73. Qin K., Zhao L., Ash R.D., McDonough W.F., and Zhao R.Y. ATM-mediated transcriptional elevation of prion in response to copper-induced oxidative stress. J. Biol. Chem. 284 (2009) 4582-4593
74. Bueler H. Normal development and behaviour of mice lacking the neuronal cell-surface PrP protein. Nature 356 (1992) 577-582
75. Isaacs J.D., Ingram R.J., Collinge J., Altmann D.M., and Jackson G.S. The human prion protein residue 129 polymorphism lies within a cluster of epitopes for T cell recognition. J. Neuropathol. Exp. Neurol. 65 (2006) 1059-1068
76. Caetano F.A., Lopes M.H., Hajj G.N., Machado C.F., Pinto Arantes C., Magalhaes A.C., Vieira Mde P., Americo T.A., Massensini A.R., Priola S.A., Vorberg I., Gomez M.V., Linden R., Prado V.F., Martins V.R., and Prado M.A. Endocytosis of prion protein is required for ERK1/2 signaling induced by stress-inducible protein 1. J. Neurosci. 28 (2008) 6691-6702
77. Collinge J., Whittington M.A., Sidle K.C., Smith C.J., Palmer M.S., Clarke A.R., and Jefferys J.G. Prion protein is necessary for normal synaptic function. Nature 370 (1994) 295-297
78. Criado J.R., Sanchez-Alavez M., Conti B., Giacchino J.L., Wills D.N., Henriksen S.J., Race R., Manson J.C., Chesebro B., and Oldstone M.B. Mice devoid of prion protein have cognitive deficits that are rescued by reconstitution of PrP in neurons. Neurobiol. Dis. 19 (2005) 255-265
79. Lobao-Soares B., Walz R., Carlotti Jr. C.G., Sakamoto A.C., Calvo F., Terzian A.L., da Silva J.A., Wichert-Ana L., Coimbra N.C., and Bianchin M.M. Cellular prion protein regulates the motor behaviour performance and anxiety-induced responses in genetically modified mice. Behav. Brain Res. 183 (2007) 87-94
80. Khosravani H., Zhang Y., Tsutsui S., Hameed S., Altier C., Hamid J., Chen L., Villemaire M., Ali Z., Jirik F.R., and Zamponi G.W. Prion protein attenuates excitotoxicity by inhibiting NMDA receptors. J. Cell Biol. 181 (2008) 551-565
81. Le Pichon C.E., Valley M.T., Polymenidou M., Chesler A.T., Sagdullaev B.T., Aguzzi A., and Firestein S. Olfactory behavior and physiology are disrupted in prion protein knockout mice. Nat. Neurosci. 12 (2009) 60-69
82. Wilson D.A., and Nixon R.A. Sniffing out a function for prion proteins. Nat. Neurosci. 12 (2009) 7-8
83. Hu W., Kieseier B., Frohman E., Eagar T.N., Rosenberg R.N., Hartung H.P., and Stuve O. Prion proteins: physiological functions and role in neurological disorders. J. Neurol. Sci. 264 (2008) 1-8
84. Isaacs J.D., Jackson G.S., and Altmann D.M. The role of the cellular prion protein in the immune system. Clin. Exp. Immunol. 146 (2006) 1-8
85. Zhang C.C., Steele A.D., Lindquist S., and Lodish H.F. Prion protein is expressed on long-term repopulating hematopoietic stem cells and is important for their self-renewal. Proc. Natl. Acad. Sci. USA 103 (2006) 2184-2189
86. Paar C., Wurm S., Pfarr W., Sonnleitner A., and Wechselberger C. Prion protein resides in membrane microclusters of the immunological synapse during lymphocyte activation. Eur. J. Cell Biol. 86 (2007) 253-264
87. Viegas P., Chaverot N., Enslen H., Perriere N., Couraud P.O., and Cazaubon S. Junctional expression of the prion protein PrPC by brain endothelial cells: a role in trans-endothelial migration of human monocytes. J. Cell Sci. 119 (2006) 4634-4643
88. Graner E. Cellular prion protein binds laminin and mediates neuritogenesis. Mol. Brain Res. 76 (2000) 85-92
89. Rieger R., Edenhofer F., Lasmezas C.I., and Weiss S. The human 37-kDa laminin receptor precursor interacts with the prion protein in eukaryotic cells. Nat. Med. 3 (1997) 1383-1388
90. Snow A.D., Wight T.N., Nochlin D., Koike Y., Kimata K., DeArmond S.J., and Prusiner S.B. Immunolocalization of heparan sulfate proteoglycans to the prion protein amyloid plaques of Gerstmann-Straussler syndrome, Creutzfeldt-Jakob disease and scrapie. Lab. Invest. 63 (1990) 601-611
91. Zanata S.M. Stress-inducible protein 1 is a cell surface ligand for cellular prion that triggers neuroprotection. EMBO J. 21 (2002) 3307-3316
92. Schmitt-Ulms G., Legname G., Baldwin M.A., Ball H.L., Bradon N., Bosque P.J., Crossin K.L., Edelman G.M., DeArmond S.J., Cohen F.E., and Prusiner S.B. Binding of neural cell adhesion molecules (N-CAMs) to the cellular prion protein. J. Mol. Biol. 314 (2001) 1209-1225
93. Santuccione A., Sytnyk V., Leshchyns'ka I., and Schachner M. Prion protein recruits its neuronal receptor NCAM to lipid rafts to activate p59fyn and to enhance neurite outgrowth. J. Cell Biol. 169 (2005) 341-354
94. Chiarini L.B., Freitas A.R., Zanata S.M., Brentani R.R., Martins V.R., and Linden R. Cellular prion protein transduces neuroprotective signals. EMBO J. 21 (2002) 3317-3326
95. Lopes M.H., Hajj G.N., Muras A.G., Mancini G.L., Castro R.M., Ribeiro K.C., Brentani R.R., Linden R., and Martins V.R. Interaction of cellular prion and stress-inducible protein 1 promotes neuritogenesis and neuroprotection by distinct signaling pathways. J. Neurosci. 25 (2005) 11330-11339
96. Knaus K.J., Morillas M., Swietnicki W., Malone M., Surewicz W.K., and Yee V.C. Crystal structure of the human prion protein reveals a mechanism for oligomerization. Nat. Struct. Biol. 8 (2001) 770-774
97. Malaga-Trillo E., Solis G.P., Schrock Y., Geiss C., Luncz L., Thomanetz V., and Stuermer C.A. Regulation of embryonic cell adhesion by the prion protein. PLoS Biol. 7 (2009) e55
98. Roucou X., and LeBlanc A.C. Cellular prion protein neuroprotective function: implications in prion diseases. J. Mol. Med. 83 (2005) 3-11
99. Kurschner C., and Morgan J.I. Analysis of interaction sites in homo- and heteromeric complexes containing Bcl-2 family members and the cellular prion protein. Brain Res. Mol. Brain Res. 37 (1996) 249-258
100. Kurschner C., and Morgan J.I. The cellular prion protein (PrP) selectively binds to Bcl-2 in the yeast two-hybrid system. Brain Res. Mol. Brain Res. 30 (1995) 165-168
101. Manson J.C., Clarke A.R., McBride P.A., McConnell I., and Hope J. PrP gene dosage determines the timing but not the final intensity or distribution of lesions in scrapie pathology. Neurodegeneration 3 (1994) 331-340
102. Moore R.C., Lee I.Y., Silverman G.L., Harrison P.M., Strome R., Heinrich C., Karunaratne A., Pasternak S.H., Chishti M.A., Liang Y., Mastrangelo P., Wang K., Smit A.F., Katamine S., Carlson G.A., Cohen F.E., Prusiner S.B., Melton D.W., Tremblay P., Hood L.E., and Westaway D. Ataxia in prion protein (PrP)-deficient mice is associated with upregulation of the novel PrP-like protein doppel. J. Mol. Biol. 292 (1999) 797-817
103. Rossi D., Cozzio A., Flechsig E., Klein M.A., Rulicke T., Aguzzi A., and Weissmann C. Onset of ataxia and Purkinje cell loss in PrP null mice inversely correlated with Dpl level in brain. EMBO J. 20 (2001) 694-702
104. Sakaguchi S., Katamine S., Nishida N., Moriuchi R., Shigematsu K., Sugimoto T., Nakatani A., Kataoka Y., Houtani T., Shirabe S., Okada H., Hasegawa S., Miyamoto T., and Noda T. Loss of cerebellar Purkinje cells in aged mice homozygous for a disrupted PrP gene. Nature 380 (1996) 528-531
105. Wong B.S., Liu T., Li R., Pan T., Petersen R.B., Smith M.A., Gambetti P., Perry G., Manson J.C., Brown D.R., and Sy M.S. Increased levels of oxidative stress markers detected in the brains of mice devoid of prion protein. J. Neurochem. 76 (2001) 565-572
106. Marciano P.G., Brettschneider J., Manduchi E., Davis J.E., Eastman S., Raghupathi R., Saatman K.E., Speed T.P., Stoeckert Jr. C.J., Eberwine J.H., and McIntosh T.K. Neuron-specific mRNA complexity responses during hippocampal apoptosis after traumatic brain injury. J. Neurosci. 24 (2004) 2866-2876
107. Shyu W.C., Kao M.C., Chou W.Y., Hsu Y.D., and Soong B.W. Heat shock modulates prion protein expression in human NT-2 cells. Neuroreport 11 (2000) 771-774
108. Walz R., Amaral O.B., Rockenbach I.C., Roesler R., Izquierdo I., Cavalheiro E.A., Martins V.R., and Brentani R.R. Increased sensitivity to seizures in mice lacking cellular prion protein. Epilepsia 40 (1999) 1679-1682
109. Hoshino S., Inoue K., Yokoyama T., Kobayashi S., Asakura T., Teramoto A., and Itohara S. Prions prevent brain damage after experimental brain injury: a preliminary report. Acta Neurochir. Suppl. 86 (2003) 297-299
110. Chesebro B., Trifilo M., Race R., Meade-White K., Teng C., LaCasse R., Raymond L., Favara C., Baron G., Priola S., Caughey B., Masliah E., and Oldstone M. Anchorless prion protein results in infectious amyloid disease without clinical scrapie. Science 308 (2005) 1435-1439
111. Fioriti L., Dossena S., Stewart L.R., Stewart R.S., Harris D.A., Forloni G., and Chiesa R. Cytosolic prion protein (PrP) is not toxic in N2a cells and primary neurons expressing pathogenic PrP mutations. J. Biol. Chem. 280 (2005) 11320-11328
112. Roucou X., Guo Q., Zhang Y., Goodyer C.G., and LeBlanc A.C. Cytosolic prion protein is not toxic and protects against Bax-mediated cell death in human primary neurons. J. Biol. Chem. 278 (2003) 40877-40881
113. Lin D.T., Jodoin J., Baril M., Goodyer C.G., and Leblanc A.C. Cytosolic prion protein is the predominant anti-Bax prion protein form: exclusion of transmembrane and secreted prion protein forms in the anti-Bax function. Biochim. Biophys. Acta 1783 (2008) 2001-2012
114. Radovanovic I., Braun N., Giger O.T., Mertz K., Miele G., Prinz M., Navarro B., and Aguzzi A. Truncated prion protein and Doppel are myelinotoxic in the absence of oligodendrocytic PrPC. J. Neurosci. 25 (2005) 4879-4888
115. Vassallo N., and Herms J. Cellular prion protein function in copper homeostasis and redox signalling at the synapse. J. Neurochem. 86 (2003) 538-544
116. Chiesa R., Piccardo P., Ghetti B., and Harris D.A. Neurological illness in transgenic mice expressing a prion protein with an insertional mutation. Neuron 21 (1998) 1339-1351
117. Chiesa R., Drisaldi B., Quaglio E., Migheli A., Piccardo P., Ghetti B., and Harris D.A. Accumulation of protease-resistant prion protein (PrP) and apoptosis of cerebellar granule cells in transgenic mice expressing a PrP insertional mutation. Proc. Natl. Acad. Sci. USA 97 (2000) 5574-5579
118. Chiesa R., Piccardo P., Quaglio E., Drisaldi B., Si-Hoe S.L., Takao M., Ghetti B., and Harris D.A. Molecular distinction between pathogenic and infectious properties of the prion protein. J. Virol. 77 (2003) 7611-7622
119. Mitteregger G., Vosko M., Krebs B., Xiang W., Kohlmannsperger V., Nolting S., Hamann G.F., and Kretzschmar H.A. The role of the octarepeat region in neuroprotective function of the cellular prion protein. Brain Pathol. 17 (2007) 174-183
120. Kuwahara C., Takeuchi A.M., Nishimura T., Haraguchi K., Kubosaki A., Matsumoto Y., Saeki K., Matsumoto Y., Yokoyama T., Itohara S., and Onodera T. Prions prevent neuronal cell-line death. Nature 400 (1999) 225-226
121. Kim B., Lee H., Choi J., Kim J., Choi E., Carp R., and YS K. The cellular prion protein (PrP (C)) prevents apoptotic neuronal cell death and mitochondrial dysfunction induced by serum deprivation. Brain Res. Mol. Brain Res. 124 (2004) 40-50
122. Nishimura T., Sakudo A., Hashiyama Y., Yachi A., Saeki K., Matsumoto Y., Ogawa M., Sakaguchi S., Itohara S., and Onodera T. Serum withdrawal-induced apoptosis in ZrchI prion protein (PrP) gene-deficient neuronal cell line is suppressed by PrP, independent of Doppel. Microbiol. Immunol. 51 (2007) 457-466
123. Bounhar Y., Zhang Y., Goodyer C.G., and LeBlanc A. Prion protein protects human neurons against Bax-mediated apoptosis. J. Biol. Chem. 276 (2001) 39145-39149
124. Roucou X., Giannopoulos P.N., Zhang Y., Jodoin J., Goodyer C.G., and LeBlanc A. Cellular prion protein inhibits proapoptotic Bax conformational change in human neurons and in breast carcinoma MCF-7 cells. Cell Death Differ. 12 (2005) 783-795
125. Jodoin J., Laroche-Pierre S., Goodyer C.G., and LeBlanc A.C. Defective retrotranslocation causes loss of anti-Bax function in human familial prion protein mutants. J. Neurosci. 27 (2007) 5081-5091
126. Li A., and Harris D.A. Mammalian prion protein suppresses Bax-induced cell death in yeast. J. Biol. Chem. 280 (2005) 17430-17434
127. Zha H., Fisk H.A., Yaffe M.P., Mahajan N., Herman B., and Reed J.C. Structure-function comparisons of the proapoptotic protein Bax in yeast and mammalian cells. Mol. Cell Biol. 16 (1996) 6494-6508
128. Sakudo A., Hamaishi M., Hosokawa-Kanai T., Tuchiya K., Nishimura T., Saeki K., Matsumoto Y., Ueda S., and Onodera T. Absence of superoxide dismutase activity in a soluble cellular isoform of prion protein produced by baculovirus expression system. Biochem. Biophys. Res. Commun. 307 (2003) 678-683
129. Sakudo A., Lee D.C., Nishimura T., Li S., Tsuji S., Nakamura T., Matsumoto Y., Saeki K., Itohara S., Ikuta K., and Onodera T. Octapeptide repeat region and N-terminal half of hydrophobic region of prion protein (PrP) mediate PrP-dependent activation of superoxide dismutase. Biochem. Biophys. Res. Commun. 326 (2005) 600-606
130. Mouillet-Richard S., Pietri M., Schneider B., Vidal C., Mutel V., Launay J.M., and Kellermann O. Modulation of serotonergic receptor signaling and cross-talk by prion protein. J. Biol. Chem. 280 (2005) 4592-4601
131. Sauer H., Dagdanova A., Hescheler J., and Wartenberg M. Redox-regulation of intrinsic prion expression in multicellular prostate tumor spheroids. Free Radic. Biol. Med. 27 (1999) 1276-1283
132. Sauer H., Wefer K., Vetrugno V., Pocchiari M., Gissel C., Sachinidis A., Hescheler J., and Wartenberg M. Regulation of intrinsic prion protein by growth factors and TNF-alpha: the role of intracellular reactive oxygen species. Free Radic. Biol. Med. 35 (2003) 586-594
133. Milhavet O., and Lehmann S. Oxidative stress and the prion protein in transmissible spongiform encephalopathies. Brain Res. Brain Res. Rev. 38 (2002) 328-339
134. Watt N.T., and Hooper N.M. Reactive oxygen species (ROS)-mediated beta-cleavage of the prion protein in the mechanism of the cellular response to oxidative stress. Biochem. Soc. Trans. 33 (2005) 1123-1125
135. Malaise M., Schatzl H.M., and Burkle A. The octarepeat region of prion protein, but not the TM1 domain, is important for the antioxidant effect of prion protein. Free Radic. Biol. Med. 45 (2008) 1622-1630
136. Brown K.L. Scrapie replication in lymphoid tissues depends on prion protein-expressing follicular dendritic cells. Nat. Med. 5 (1999) 1308-1312
137. Jones S., Batchelor M., Bhelt D., Clarke A.R., Collinge J., and Jackson G.S. Recombinant prion protein does not possess SOD-1 activity. Biochem. J. 392 (2005) 309-312
138. Hutter G., Heppner F.L., and Aguzzi A. No superoxide dismutase activity of cellular prion protein in vivo. Biol. Chem. 384 (2003) 1279-1285
139. Brown D.R., Schulz-Schaeffer W.J., Schmidt B., and Kretzschmar H.A. Prion protein-deficient cells show altered response to oxidative stress due to decreased SOD-1 activity. Exp. Neurol. 146 (1997) 104-112
140. Brown D.R., Nicholas R.S., and Canevari L. Lack of prion protein expression results in a neuronal phenotype sensitive to stress. J. Neurosci. Res. 67 (2002) 211-224
141. Klamt F., Dal-Pizzol F., Conte da Frota M.J., Walz R., Andrades M.E., da Silva E.G., Brentani R.R., Izquierdo I., and Fonseca Moreira J.C. Imbalance of antioxidant defense in mice lacking cellular prion protein. Free Radic. Biol. Med. 30 (2001) 1137-1144
142. White A.R., Collins S.J., Maher F., Jobling M.F., Stewart L.R., Thyer J.M., Beyreuther K., Masters C.L., and Cappai R. Prion protein-deficient neurons reveal lower glutathione reductase activity and increased susceptibility to hydrogen peroxide toxicity. Am. J. Pathol. 155 (1999) 1723-1730
143. Halliwell B. Oxidative stress and neurodegeneration: where are we now?. J. Neurochem. 97 (2006) 1634-1658
144. Choi C.J., Anantharam V., Saetveit N.J., Houk R.S., Kanthasamy A., and Kanthasamy A.G. Normal cellular prion protein protects against manganese-induced oxidative stress and apoptotic cell death. Toxicol. Sci. 98 (2007) 495-509
145. Rambold A.S., Miesbauer M., Olschewski D., Seidel R., Riemer C., Smale L., Brumm L., Levy M., Gazit E., Oesterhelt D., Baier M., Becker C.F., Engelhard M., Winklhofer K.F., and Tatzelt J. Green tea extracts interfere with the stress-protective activity of PrP and the formation of PrP. J. Neurochem. 107 (2008) 218-229
146. Anantharam V., Kanthasamy A., Choi C.J., Martin D.P., Latchoumycandane C., Richt J.A., and Kanthasamy A.G. Opposing roles of prion protein in oxidative stress- and ER stress-induced apoptotic signaling. Free Radic. Biol. Med. 45 (2008) 1530-1541
147. Walmsley A.R., Zeng F., and Hooper N.M. The N-terminal region of the prion protein ectodomain contains a lipid raft targeting determinant. J. Biol. Chem. 278 (2003) 37241-37248
148. Drisaldi B., Coomaraswamy J., Mastrangelo P., Strome B., Yang J., Watts J.C., Chishti M.A., Marvi M., Windl O., Ahrens R., Major F., Sy M.S., Kretzschmar H., Fraser P.E., Mount H.T., and Westaway D. Genetic mapping of activity determinants within cellular prion proteins: N-terminal modules in PrPC offset pro-apoptotic activity of the Doppel helix B/B′ region. J. Biol. Chem. 279 (2004) 55443-55454
149. Atarashi R., Nishida N., Shigematsu K., Goto S., Kondo T., Sakaguchi S., and Katamine S. Deletion of N-terminal residues 23-88 from prion protein (PrP) abrogates the potential to rescue PrP-deficient mice from PrP-like protein/doppel-induced neurodegeneration. J. Biol. Chem. 278 (2003) 28944-28949
150. Qin K., Zhao L., Tang Y., Bhatta S., Simard J.M., and Zhao R.Y. Doppel-induced apoptosis and counteraction by cellular prion protein in neuroblastoma and astrocytes. Neuroscience 141 (2006) 1375-1388
151. Li A., Piccardo P., Barmada S.J., Ghetti B., and Harris D.A. Prion protein with an octapeptide insertion has impaired neuroprotective activity in transgenic mice. EMBO J. 26 (2007) 2777-2785
152. Rosenmann H., Talmor G., Halimi M., Yanai A., Gabizon R., and Meiner Z. Prion protein with an E200K mutation displays properties similar to those of the cellular isoform PrP(C). J. Neurochem. 76 (2001) 1654-1662
153. Paitel E., Sunyach C., Alves da Costa C., Bourdon J.C., Vincent B., and Checler F. Primary cultured neurons devoid of cellular prion display lower responsiveness to staurosporine through the control of p53 at both transcriptional and post-transcriptional levels. J. Biol. Chem. 279 (2004) 612-618
154. Paitel E., Fahraeus R., and Checler F. Cellular prion protein sensitizes neurons to apoptotic stimuli through Mdm2-regulated and p53-dependent caspase 3-like activation. J. Biol. Chem. 278 (2003) 10061-10066
155. Solforosi L., Criado J.R., McGavern D.B., Wirz S., Sanchez-Alavez M., Sugama S., DeGiorgio L.A., Volpe B.T., Wiseman E., Abalos G., Masliah E., Gilden D., Oldstone M.B., Conti B., and Williamson R.A. Cross-linking cellular prion protein triggers neuronal apoptosis in vivo. Science 303 (2004) 1514-1516
156. Wu G., Nakajima K., Takeyama N., Yukawa M., Taniuchi Y., Sakudo A., and Onodera T. Species-specific anti-apoptotic activity of cellular prion protein in a mouse PrP-deficient neuronal cell line transfected with mouse, hamster, and bovine Prnp. Neurosci. Lett. 446 (2008) 11-15
157. Kim P.K., Annis M.G., Dlugosz P.J., and Andrews L.B.D.W. During apoptosis bcl-2 changes membrane topology at both the endoplasmic reticulum and mitochondria. Mol. Cell 14 (2004) 523-529
158. Lin B., et al. Conversion of Bcl-2 from protector to killer by interaction with nuclear orphan receptor Nur77/TR3. Cell 116 (2004) 527-540
159. Clem R., Cheng E.H., Karp C.L., Kirsch D.G., Ueno K., Takahashi A., Kastan M.B., Griffin D.E., Earnshaw W.C., Veliuona M.A., and JM H. Modulation of cell death by Bcl-XL through caspase interaction. Proc. Natl. Acad. Sci. USA 95 (1998) 554-559
160. Vanhaesebroeck B., Reed J.C., De Valck D., Grooten J., Miyashita T., Tanaka S., Beyaert R., Van Roy F., and Fiers W. Effect of bcl-2 proto-oncogene expression on cellular sensitivity to tumor necrosis factor-mediated cytotoxicity. Oncogene 8 (1993) 1075-1081
161. Ghetti B., Piccardo P., Spillantini M.G., Ichimiya Y., Porro M., Perini F., Kitamoto T., Tateishi J., Seiler C., Frangione B., Bugiani O., Giaccone G., Prelli F., Goedert M., Dlouhy S.R., and F T. Vascular variant of prion protein cerebral amyloidosis with tau-positive neurofibrillary tangles: the phenotype of the stop codon 145 mutation in PRNP. Proc. Natl. Acad. Sci. USA 93 (1996) 744-748
162. Liberski P.P., Brown D.R., Sikorska B., Caughey B., and Brown P. Cell death and autophagy in prion diseases (transmissible spongiform encephalopathies). Folia Neuropatholo. 46 (2008) 1-25
163. Dron M., Bailly Y., Beringue V., Haeberle A.M., Griffond B., Risold P.Y., Tovey M.G., Laude H., and Dandoy-Dron F. SCRG1, a potential marker of autophagy in transmissible spongiform encephalopathies. Autophagy 2 (2006) 58-60
164. Heitz S., Grant N.J., Leschiera R., Haeberle A.M., Demais V., Bombarde G., and Bailly Y. Autophagy and cell death of Purkinje cells overexpressing doppel in Ngsk Prnp-deficient mice. Brain Pathol. (2008)
165. Oh J.M., Shin H.Y., Park S.J., Kim B.H., Choi J.K., Choi E.K., Carp R.I., and Kim Y.S. The involvement of cellular prion protein in the autophagy pathway in neuronal cells. Mol. Cell. Neurosci. 39 (2008) 238-247
166. Hanahan D., and Weinberg R.A. The hallmarks of cancer. Cell 100 (2000) 57-70
167. Green D.R., and Evan G.I. A matter of life and death. Cancer Cell 1 (2002) 19-30
168. Johnstone R.W., Ruefli A.A., and Lowe S.W. Apoptosis: a link between cancer genetics and chemotherapy. Cell 108 (2002) 153-164
169. Diarra-Mehrpour M., Arrabal S., Jalil A., Pinson X., Gaudin C., Pietu G., Pitaval A., Ripoche H., Eloit M., Dormont D., and Chouaib S. Prion protein prevents human breast carcinoma cell line from tumor necrosis factor alpha-induced cell death. Cancer Res. 64 (2004) 719-727
170. Clohessy J.G., Zhuang J., de Boer J., Gil-Gomez G., and Brady H.J. Mcl-1 interacts with truncated Bid and inhibits its induction of cytochrome c release and its role in receptor-mediated apoptosis. J. Biol. Chem. 281 (2006) 5750-5759
171. Laroche-Pierre S., Jodoin J., and LeBlanc A.C. Helix 3 is necessary and sufficient for prion protein's anti-Bax function. J. Neurochem. 108 (2009) 1019-1031
172. McGrogan B.T., Gilmartin B., Carney D.N., and McCann A. Taxanes, microtubules and chemoresistant breast cancer. Biochim. Biophys. Acta 1785 (2008) 96-132
173. Li Q.Q., Cao X.X., Xu J.D., Chen Q., Wang W.J., Tang F., Chen Z.Q., Liu X.P., and Xu Z.D. The role of P-glycoprotein/cellular prion protein interaction in multidrug-resistant breast cancer cells treated with paclitaxel. Cell Mol. Life Sci. 66 (2009) 504-515
174. Srivastava R.K., Mi Q.S., Hardwick J.M., and Longo D.L. Deletion of the loop region of Bcl-2 completely blocks paclitaxel-induced apoptosis. Proc. Natl. Acad. Sci. USA 96 (1999) 3775-3780
175. Du J., Pan Y., Shi Y., Guo C., Jin X., Sun L., Liu N., Qiao T., and Fan D. Overexpression and significance of prion protein in gastric cancer and multidrug-resistant gastric carcinoma cell line SGC7901/ADR. Int. J. Cancer 113 (2005) 213-220
176. Liang J., Bai F., Luo G., Wang J., Liu J., Ge F., Pan Y., Yao L., Du R., Li X., Fan R., Zhang H., Guo X., Wu K., and Fan D. Hypoxia induced overexpression of PrP(C) in gastric cancer cell lines. Cancer Biol. Ther. 6 (2007) 769-774
177. Liang J., Ge F., Guo C., Luo G., Wang X., Han G., Zhang D., Wang J., Li K., Pan Y., Yao L., Yin Z., Guo X., Wu K., Ding J., and Fan D. Inhibition of PI3K/Akt partially leads to the inhibition of PrP(C)-induced drug resistance in gastric cancer cells. FEBS J. 276 (2009) 685-694
178. Erlich R.B., Kahn S.A., Lima F.R., Muras A.G., Martins R.A., Linden R., Chiarini L.B., Martins V.R., and Moura Neto V. STI1 promotes glioma proliferation through MAPK and PI3K pathways. Glia 55 (2007) 1690-1698
179. Pan Y., Zhao L., Liang J., Liu J., Shi Y., Liu N., Zhang G., Jin H., Gao J., Xie H., Wang J., Liu Z., and Fan D. Cellular prion protein promotes invasion and metastasis of gastric cancer. FASEB J. 20 (2006) 1886-1888
180. Liang J., Pan Y., Zhang D., Guo C., Shi Y., Wang J., Chen Y., Wang X., Liu J., Guo X., Chen Z., Qiao T., and Fan D. Cellular prion protein promotes proliferation and G1/S transition of human gastric cancer cells SGC7901 and AGS. FASEB J. 21 (2007) 2247-2256
181. Liang J., Wang J.B., Pan Y.L., Wang J., Liu L.L., Guo X.Y., Sun L., Lin T., Han S., Xie H.H., Yin F., Guo X.G., and Fan D. High frequency occurrence of 1-OPRD variant of PRNP gene in gastric cancer cell lines and Chinese population with gastric cancer. Cell Biol. Int. 30 (2006) 920-923
182. Liang J., Wang J., Luo G., Pan Y., Han G., Wang X., Guo C., Zhang D., Yin F., Zhang X., Liu J., Wang J., Guo X., Wu K., and Fan D. Function of PrP(C)(1-OPRD) in biological activities of gastric cancer cell lines. J. Cell. Mol. Med. (2009)
183. Watts J.C., and Westaway D. The prion protein family: diversity, rivalry, and dysfunction. Biochim. Biophys. Acta 1772 (2007) 654-672
184. West D.C., Rees C.G., Duchesne L., Patey S.J., Terry C.J., Turnbull J.E., Delehedde M., Heegaard C.W., Allain F., Vanpouille C., Ron D., and Fernig D.G. Interactions of multiple heparin binding growth factors with neuropilin-1 and potentiation of the activity of fibroblast growth factor-2. J. Biol. Chem. 280 (2005) 13457-13464